Core Viewpoint - The article highlights the performance of Zhejiang Shibao Co., Ltd., which has a significant A/H share premium and is recognized as a leading enterprise in the automotive steering system industry in China [1][2]. Company Overview - Zhejiang Shibao Co., Ltd. was established in 1984 and focuses on the research, development, manufacturing, and sales of automotive steering system products [1]. - The company was recognized as a "leading enterprise in the automotive steering gear industry" by the China Association of Automobile Manufacturers in 2009 and has been a key participant in setting steering gear standards in China [1]. - It has been awarded the title of "one of the top 100 excellent automotive parts suppliers in the country" for several consecutive years [1]. Business Strategy - The company adheres to a business philosophy of "pragmatism and innovation," continuously introducing advanced technologies and production testing equipment [1]. - It gathers domestic and international experts, technical talents, and management elites to enhance its operational capabilities [1]. - The implementation of lean production management aims to provide high-quality products and excellent services to both domestic and international customers [1]. Market Position - Zhejiang Shibao aims to develop into an internationally recognized brand in automotive steering systems and to become a long-term trusted partner for many well-known automobile manufacturers globally [1].

Group 1 - The Shanghai Composite Index rose by 0.66% to close at 3583.31 points, while the Hang Seng Index increased by 0.92% to 24733.45 points [1] - The premium of Haiprui's A-shares over H-shares reached 131.61%, ranking 14th among AH shares in terms of premium rate [1] - Haiprui's A-shares closed at 13.17 yuan, down 0.6%, and H-shares closed at 6.22 Hong Kong dollars, remaining flat [1] Group 2 - Shenzhen Haiprui Pharmaceutical Group Co., Ltd. was established in 1998 and is a leading multinational pharmaceutical company with A+H dual financing platforms [1] - The company operates across the entire heparin industry chain, biopharmaceutical CDMO, and the investment, development, and commercialization of innovative drugs [1] - Haiprui's three business segments are synergistic and driven by unmet clinical needs, aiming to provide high-quality, safe, and effective drugs and services to global patients [1]

8月4日，上证指数涨0.66%，收报3583.31点，恒生指数涨0.92%，收报24733.45点。 长城汽车AH溢价达81.93%，位居AH股溢价率第44位。当日收盘，长城汽车A股报22.22元，涨幅 2.4%，H股报13.36港元，上涨5.03%。 本文源自：金融界 作者：行情君 *注：AH股是指同时在A股和港股上市的公司，溢价（A/H）越大，说明H股相比A股越便宜。 资料显示，长城汽车股份有限公司是一家全球化智能科技公司,业务包括汽车及零部件设计、研发、生 产、销售和服务,旗下拥有哈弗、魏牌、欧拉、坦克及长城皮卡。长城汽车打造了以能源、智能化为导 向的森林生态体系,确立混动、纯电、氢能三轨并行发展,在智能驾驶、智能座舱、智慧底盘等方面进行 全产业链布局,构建了业内领先的"光伏+分布式储能+集中式储能"的能源体系,完成了"太阳能-电池-氢能- 车用动力"的全价值链布局。 ...

Core Viewpoint - The article highlights the performance of Vanke Co., Ltd., a leading urban construction and living service provider in China, noting its significant A/H share premium and its consistent ranking in the Fortune Global 500 list over the years [1]. Group 1: Company Performance - On August 4, the Shanghai Composite Index rose by 0.66% to close at 3583.31 points, while the Hang Seng Index increased by 0.92% to 24733.45 points [1]. - Vanke A shares closed at 6.41 yuan, with a gain of 0.31%, and H shares closed at 4.91 Hong Kong dollars, up by 0.2% [1]. - Vanke's A/H share premium reached 42.8%, ranking it 91st among A/H shares [1]. Group 2: Company Background - Vanke was established in 1984 and has developed into a leading urban construction and living service provider in China, focusing on the most dynamic economic zones and key cities in the central and western regions [1]. - Since first entering the Fortune Global 500 list in 2016, Vanke has been listed for nine consecutive years, ranking 206th in 2024 [1]. - The company has evolved its positioning from a "good residential supplier" in 2014 to an "urban supporting service provider," and further upgraded this to "urban construction and living service provider" in 2018, detailing four roles: creator of beautiful living scenarios, driving force of the real economy, innovation exploration laboratory, and harmonious ecological builder [1].

8月4日，上证指数涨0.66%，收报3583.31点，恒生指数涨0.92%，收报24733.45点。 中远海发AH溢价达133.86%，位居AH股溢价率第13位。当日收盘，中远海发A股报2.48元，涨幅 0.4%，H股报1.16港元，下跌0.85%。 资料显示，中远海运发展股份有限公司(「公司」)是中国远洋海运集团有限公司(「中远海运集团」)所 属专门从事航运物流产融运营的公司,是中远海运集团旗下核心产业之一。公司成立于1997年,总部设在 上海,是一家在香港、上海两地上市的公司。公司致力于围绕航运物流产业主线,以集装箱制造、集装箱 租赁及航运租赁业务为核心,以投资管理为支撑,实现产融投一体化发展。公司集装箱制造业务从事国际 标准干货箱、冷藏箱及特种箱的研究开发和生产销售,设计年产能超过140万TEU,位居世界第二,客户涵 盖全球知名班轮公司和各大租箱公司。公司深化集装箱租造协同,以科技创新、绿色低碳转型为抓手提 升核心竞争力,打造世界一流物流装备科技企业。 *注：AH股是指同时在A股和港股上市的公司，溢价（A/H）越大，说明H股相比A股越便宜。 本文源自：金融界 作者：行情君 ...

Group 1 - The Shanghai Composite Index fell by 0.37% to close at 3559.95 points, while the Hang Seng Index decreased by 1.07% to 24507.81 points [1] - China Galaxy Securities Co., Ltd. has an AH premium of 79.1%, ranking 45th in terms of AH stock premium rates [1] - At the close, China Galaxy's A-shares were priced at 16.98 yuan, down 1.28%, and H-shares were at 10.32 Hong Kong dollars, down 2.82% [1] Group 2 - China Galaxy Securities is a leading comprehensive financial service provider in China's securities industry, known for its historical, brand, and shareholder advantages [1] - The company ranks among the top in the industry in terms of capital scale, profitability, business strength, and risk management capabilities [1] - It offers a wide range of financial services including wealth management, investment banking, institutional business, international business, and investment trading to individual, corporate, institutional, international, and capital market clients [1]

Group 1 - The core viewpoint of the article highlights the performance of the Shanghai Composite Index and the Hang Seng Index, with the former declining by 0.37% to close at 3559.95 points and the latter dropping by 1.07% to 24507.81 points [1] - Fudan Zhangjiang's A/H share premium reached 182.7%, ranking fourth among A/H shares, with A-shares closing at 10.83 yuan (up 0.19%) and H-shares at 4.17 HKD (up 1.96%) [1] - Fudan Zhangjiang Biopharmaceutical Co., Ltd. was established in November 1996 in the Zhangjiang Hi-Tech Park, Shanghai, with notable shareholders including Shanghai Pharmaceuticals Holding Co., Ltd. [1] Group 2 - The company focuses on innovative research, development, production, and sales in the biopharmaceutical sector, aiming to become a knowledge-based innovation enterprise [1] - Fudan Zhangjiang has developed competitive advantages in areas such as gene technology drugs, photodynamic therapy drugs, nanotechnology drugs, and oral solid dosage technology drugs, with new products expected to be launched in the market [1] - The company has undertaken several national key science and technology projects, including the "National Key Technology R&D Program," "National High Technology Research and Development Program (863 Program)," and "Major New Drug Creation" projects [1]

Group 1 - The Shanghai Composite Index fell by 0.37% to close at 3559.95 points, while the Hang Seng Index decreased by 1.07% to 24507.81 points [1] - China Merchants Industry Holdings Co., Ltd. (the "Company") has an A/H premium of 129.79%, ranking 15th among A/H shares [1] - The Company’s A-shares closed at 2.47 yuan, down 0.8%, and H-shares closed at 1.17 HKD, remaining flat [1] Group 2 - The Company is a subsidiary of China Ocean Shipping Group Co., Ltd. and specializes in shipping logistics and financial operations [1] - Established in 1997 and headquartered in Shanghai, the Company is listed in both Hong Kong and Shanghai [1] - The Company focuses on container manufacturing, leasing, and shipping leasing, supported by investment management for integrated development [1] - The container manufacturing business has an annual design capacity exceeding 1.4 million TEU, making it the second largest in the world [1] - The Company serves global renowned shipping lines and major leasing companies, enhancing its core competitiveness through technological innovation and green transformation [1]

Group 1 - The Shanghai Composite Index fell by 0.37% to close at 3559.95 points, while the Hang Seng Index decreased by 1.07% to 24507.81 points [1] - Hongye Futures has the highest A/H premium at 206.73%, indicating that its H-shares are relatively cheaper compared to A-shares [1] - Hongye Futures' A-shares closed at 11.92 yuan, down 0.58%, and its H-shares closed at 4.23 HKD, down 2.98% [1] Group 2 - Hongye Futures Co., Ltd. was established in 1995 and is a state-owned enterprise fully owned by Jiangsu Provincial State-owned Assets Supervision and Administration Commission [1] - The company operates in various sectors including commodity futures brokerage, financial futures brokerage, futures investment consulting, asset management, and fund sales, with 38 branches in major financial centers across China [1] - Hongye International Finance, a wholly-owned subsidiary, focuses on overseas securities and futures trading, asset management, and investment consulting, covering major global exchanges [1] - Hongye Capital, another wholly-owned risk management subsidiary, specializes in bulk commodity trading and risk management, serving as a market maker for multiple futures varieties [1] - The company has received several honors, including "National Civilized Unit" and "China's Best Futures Company" [1]

Group 1 - The Shanghai Composite Index fell by 0.37% to close at 3559.95 points, while the Hang Seng Index decreased by 1.07% to 24507.81 points [1] - Liaoning Port Co., Ltd. (referred to as Liao Port) has an AH premium of 103.1%, ranking 30th among AH shares [1] - Liao Port's A-shares closed at 1.53 yuan, while its H-shares closed at 0.82 Hong Kong dollars, both remaining flat [1] Group 2 - Liao Port was established from the merger of Dalian Port Co., Ltd. and Yingkou Port Co., Ltd. in February 2021, and it is the first port company in China to have both A and H share financing platforms [1] - The company's operations cover various cargo types including containers, oil products, bulk goods, and passenger roll-on/roll-off services, primarily located in four major port areas: Dalian and Yingkou [1] - Liao Port is one of the largest publicly listed companies in the northern region of China in terms of assets, revenue, and profit within the port industry [1]